AMICUS THERAPEUTICS, INC. (FOLD) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$634.2M

Net Income/Loss (FY2025)

-$27.1M

Total Assets (FY2025)

$949.9M

Total Equity (FY2025)

$274.2M

Cash Flows from Operating Activities (FY2025)

$33.1M

Source: AMICUS THERAPEUTICS, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.